FSLR
55
-11
MAC
68
-2
PFG
68
-5
NFLX
37
2
KLAC
67
-7
LMT
62
2
TJX
66
11
D
41
4
ILMN
70
-4
AN
52
-13
AEP
59
-2
MA
55
2
STT
73
-4
SRE
54
-5
NTAP
60
-6
IR
71
3
CFG
93
-2
SLB
49
-4
PNC
76
-6
FFIV
54
-2
FSLR
55
-11
MAC
68
-2
PFG
68
-5
NFLX
37
2
KLAC
67
-7
LMT
62
2
TJX
66
11
D
41
4
ILMN
70
-4
AN
52
-13
AEP
59
-2
MA
55
2
STT
73
-4
SRE
54
-5
NTAP
60
-6
IR
71
3
CFG
93
-2
SLB
49
-4
PNC
76
-6
FFIV
54
-2
Financhill
Back

Franklin US Core Dividend Tilt Index ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
49

UDIV
Franklin US Core Dividend Tilt Index ETF

Last Price:
$53.28
Seasonality Move:
4.35%
Sell
39

NKTR
Nektar Therapeutics

Last Price:
$53.66
Seasonality Move:
11.58%
Sell
49
Franklin US Core Dividend Tilt Index ETF (UDIV) is a Sell

Is Franklin US Core Dividend Tilt Index ETF a Buy, Sell or Hold?

  • The current Franklin US Core Dividend Tilt Index ETF [UDIV] share price is $53.28. The Score for UDIV is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • UDIV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $54.70. The Score for NKTR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

UDIV Stock Price Chart

What is Franklin US Core Dividend Tilt Index ETF's stock price today?

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $54.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

UDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 53.74 Buy
Chaikin Money Flow: 541 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.98 - 53.62) Buy
Bollinger Bands (100): (50.39 - 53.05) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.71 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 141668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.71 - 61.07) Sell
Bollinger Bands (100): (32.74 - 62.56) Buy

UDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.57 Sell
20-day SMA: 52.77 Buy
50-day SMA: 52.7 Buy
200-day SMA: 48.44 Buy
8-day EMA: 53.47 Sell
20-day EMA: 53.11 Buy
50-day EMA: 52.58 Buy
200-day EMA: 49.51 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.42 Sell
20-day SMA: 58.12 Sell
50-day SMA: 58.41 Sell
200-day SMA: 30.65 Buy
8-day EMA: 56.16 Sell
20-day EMA: 57.43 Sell
50-day EMA: 55.78 Sell
200-day EMA: 37.86 Buy

Franklin US Core Dividend Tilt Index ETF Earnings Growth & UDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Franklin US Core Dividend Tilt Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):